Overall rank by patents
#3,025
Across all tracked assignees
USPTO PatentsView assignee record — 126 granted patents across 23 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
SUN holds 126 US patents across 23 technology areas — rank #3,025 of 50,000 tracked assignees.
SUN PHARMACEUTICAL INDUSTRIES LIMITED has been granted 126 US utility patents between 2015 and 2025, placing SUN PHARMACEUTICAL INDUSTRIES LIMITED at rank #3,025 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, SUN PHARMACEUTICAL INDUSTRIES LIMITED is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 49.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 62 grants, compared with 64 in the 2015–2019 window — a -3% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SUN PHARMACEUTICAL INDUSTRIES LIMITED's 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SUN PHARMACEUTICAL INDUSTRIES LIMITED against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
SUN PHARMACEUTICAL INDUSTRIES LIMITED
126 patents
What this shows SUN holds 126 patents — placing it at rank #3,025 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
SUN's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 0.8% |
| 2016 | 9 | 7.1% |
| 2017 | 21 | 16.7% |
| 2018 | 18 | 14.3% |
| 2019 | 15 | 11.9% |
| 2020 | 5 | 4.0% |
| 2021 | 13 | 10.3% |
| 2022 | 14 | 11.1% |
| 2023 | 4 | 3.2% |
| 2024 | 17 | 13.5% |
| 2025 | 9 | 7.1% |
Top 15 of 23 technology areas
Overall rank by patents
#3,025
Across all tracked assignees
49.1 out of 100
SUN PHARMACEUTICAL INDUSTRIES LIMITED's primary CPC class — all holders and yearly trends
See where SUN PHARMACEUTICAL INDUSTRIES LIMITED ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.